Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: August 2010

Chapter 2 - Screening and prevention of gynaecological cancers

Further reading

Cancer Research UK. Latest UK summary – cancer incidence 2004 and mortality 2005. Cancer Research UK, 2007. Available at: http://info.cancerresearchuk.org/images/pdfs/2004inc2005mortpdf.
JacobsI, OramD, FairbanksJ, TurnerJ, FrostC, GrudzinskasJ G.A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990; 97: 922–9.
National Institute for Clinical Excellence (NICE). Guidance on the Use of Liquid-based Cytology for Cervical Screening. London: National Institute for Clinical Excellence, 2003.
NHS Cancer Screening Programmes. Colposcopy and Programme Management – Guidelines for the NHS Cervical Screening Programme. London: NHS Cancer Screening Programmes, 2004.
SasieniP, AdamsJ, CuzickJ.Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003; 89: 88–93.
WilsonJ, JungerG.Principles and Practice of Screening for Disease. Public Health Papers no. 34. Geneva: World Health Organization, 1968: 66–7.
WrightT C, Jr, MassadL S, DuntonC J, SpitzerM, WilkinsonE J, SolomonD. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007; 197: 340–5.